NSCLC KRAS G12C MUTANT CELLS ARE DEPENDENT ON MUC1-C FOR RESISTANCE TO KRAS INHIBITORS (human)
We performed whole-exome sequencing (WES) to compare the parental and daraxonrasib-resistant cells to investigate the acquisition of novel genetic mutations.